Chief People Officer Linda Llewelyn of Health Catalyst Inc (HCAT, Financial) executed a sale of 1,365 shares of the company on November 15, 2024, according to a recent SEC Filing. Following this transaction, the insider now owns 112,910 shares of the company.
Health Catalyst Inc is a provider of data and analytics technology and services to healthcare organizations. The company's solutions include a data platform, analytics software, and professional services that are geared towards improving clinical, financial, and operational outcomes.
Over the past year, Linda Llewelyn has sold a total of 20,323 shares and has not made any purchases of the company's stock. The insider transaction history for Health Catalyst Inc shows a pattern of more sales than purchases among insiders, with 25 insider sells and only 1 insider buy over the past year.
On the date of the sale, shares of Health Catalyst Inc were trading at $8.5. The company has a market cap of approximately $459.947 million. According to the GF Value, the intrinsic value estimate for Health Catalyst Inc is $10.81 per share, suggesting that the stock might be undervalued with a price-to-GF-Value ratio of 0.79. This valuation indicates that the stock is a Possible Value Trap, Think Twice before investing.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted by a GuruFocus factor based on past returns and growth, and future business performance estimates from analysts.
This recent insider sale might provide current and potential investors with important cues about the perceived value of Health Catalyst Inc, considering the ongoing insider selling trend and the current valuation metrics.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
